|
|
||||||||


Swiss Institute of Allergy and Asthma Research (SIAF), CH-7270 Davos, Switzerland;
* Division of Cellular Biochemistry, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands;
Department of Microbiology and Immunology, Tohoku University School of Medicine, Aoba-ku, Sendai 980-8575 Japan; and
Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Midori-ku, Yokohama 226, Japan
1Correspondence: Swiss Institute of Allergy and Asthma Research (SIAF), Obere Str. 22, CH-7270 Davos, Switzerland. E-mail: csweber{at}siaf.unizh.ch
Transforming growth factor-ß1 (TGF-ß1) is a pluripotent cytokine that controls peripheral T cell tolerance mainly in mucosal immunity. It is secreted by regulatory T cells (Tr /Th3) but also by other immununologically active cells. Smad anchor for receptor activation (SARA) and hepatic growth factor-regulated tyrosine kinase substrate (Hgs) are involved in TGF-ß1 signaling. Both molecules are known to present Smad2 and Smad3 to the TGF-ß receptor complex. The role of SARA and Hgs in TGF-ß1 susceptibility of human CD4+ T cells is unclear. We demonstrate here that TGF-ß1 up-regulates SARA mRNA expression in CD4+ T cells similar to that of Smad7. However, the increase in SARA expression was lower (6.1±0.3-fold vs. 25±4.1-fold) compared with Smad7 and delayed, with a maximum at 12 h compared with 2 h. Th1 and Th2 cell subsets expressed the same levels of SARA and Hgs. Compared with resting cells, significantly lower levels of the two molecules were found in antigen/allergen- or anti-CD3/CD28-stimulated cells. Down-regulation of SARA and Hgs mRNA in preactivated CD4+ T cells was accompanied by a twofold increase in a TGF-ß1 responsive reporter gene assay. Overexpression of SARA and Hgs in T cells yielded a dose-dependent decrease in cotransfected reporter gene expression, indicating an inhibitory function of both molecules. Thus, SARA and Hgs are regulators of TGF-ß1 susceptibility in T cells and integrate regulatory signals into the influence of TGF-ß1-mediated suppression of human T cells.Kunzmann, S., Wohlfahrt, J. G., Itoh, S., Asao, H., Komada, M., Akdis, C. A., Blaser, K., Schmidt-Weber, C. B. SARA and Hgs attenuate susceptibility to TGF-ß1-mediated T cell suppression.
Key Words: SARA Hgs TGF-ß1 CD4+ T cells T cell tolerance nucleofection
This article has been cited by other articles:
![]() |
Y.-G. Chen, Z. Wang, J. Ma, L. Zhang, and Z. Lu Endofin, a FYVE Domain Protein, Interacts with Smad4 and Facilitates Transforming Growth Factor-beta Signaling J. Biol. Chem., March 30, 2007; 282(13): 9688 - 9695. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Y. Mantel, N. Ouaked, B. Ruckert, C. Karagiannidis, R. Welz, K. Blaser, and C. B. Schmidt-Weber Molecular Mechanisms Underlying FOXP3 Induction in Human T Cells J. Immunol., March 15, 2006; 176(6): 3593 - 3602. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Schmidt-Weber, M. Letarte, S. Kunzmann, B. Ruckert, C. Bernabeu, and K. Blaser TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin Int. Immunol., July 1, 2005; 17(7): 921 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pan, L. D. Estevez-Salmeron, S. L. Stroschein, X. Zhu, J. He, S. Zhou, and K. Luo The Integral Inner Nuclear Membrane Protein MAN1 Physically Interacts with the R-Smad Proteins to Repress Signaling by the Transforming Growth Factor-{beta} Superfamily of Cytokines J. Biol. Chem., April 22, 2005; 280(16): 15992 - 16001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Steller, T. J. Shaw, B. C. Vanderhyden, and J.-F. Ethier Inhibin Resistance Is Associated with Aggressive Tumorigenicity of Ovarian Cancer Cells Mol. Cancer Res., January 1, 2005; 3(1): 50 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Akdis, J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, et al. Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells J. Exp. Med., June 7, 2004; 199(11): 1567 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Wohlfahrt, C. Karagiannidis, S. Kunzmann, M. M. Epstein, W. Kempf, K. Blaser, and C. B. Schmidt-Weber Ephrin-A1 Suppresses Th2 Cell Activation and Provides a Regulatory Link to Lung Epithelial Cells J. Immunol., January 15, 2004; 172(2): 843 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Walter-Yohrling, X. Cao, M. Callahan, W. Weber, S. Morgenbesser, S. L. Madden, C. Wang, and B. A. Teicher Identification of Genes Expressed in Malignant Cells That Promote Invasion Cancer Res., December 15, 2003; 63(24): 8939 - 8947. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Tiemessen, S. Kunzmann, C. B. Schmidt-Weber, J. Garssen, C. A. F. M. Bruijnzeel-Koomen, E. F. Knol, and E. Van Hoffen Transforming growth factor-{beta} inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response Int. Immunol., December 1, 2003; 15(12): 1495 - 1504. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Song, S. C. Cornelius, M. Reiss, and D. Danielpour Insulin-like Growth Factor-I Inhibits Transcriptional Responses of Transforming Growth Factor-{beta} by Phosphatidylinositol 3-Kinase/Akt-dependent Suppression of the Activation of Smad3 but Not Smad2 J. Biol. Chem., October 3, 2003; 278(40): 38342 - 38351. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |